Skip to main content
Journal of Thoracic Disease logoLink to Journal of Thoracic Disease
letter
. 2020 Jul;12(7):3911–3912. doi: 10.21037/jtd-20-1984

Preoperative risk factors of early right ventricular failure—following left ventricular assist device implantation

Teruhiko Imamura 1,✉
PMCID: PMC7399435  PMID: 32802478

Preoperative risk stratification and perioperative management of postoperative right ventricular failure following left ventricular assist device (LVAD) implantation are receiving great concerns. Carmona and colleagues demonstrated that LVAD implantation by thoracotomy instead of sternotomy had an advantage in reducing the risk of post-operative right ventricular failure. There are several concerns that should improve their findings (1).

In their novel surgical approach strategy, a sternotomy is recommended for LVAD implantation and concomitant mitral and/or tricuspid valve surgeries. Sternotomy-related factors including longer cardiopulmonary bypass time and perioperative blood transfusion would have association with the development of right ventricular failure as the authors stated (2), whereas concomitant valve surgeries themselves might also have negative impacts on right ventricle. Outcome comparison between the sternotomy and thoracotomy among those with LVAD implantation alone might exclude the effects of such confounders.

Second, several preoperative hemodynamic data seem to have association with postoperative right ventricular failure, including pulmonary vascular resistance, pulmonary artery pulsatility index, and right ventricular stroke work index (2,3). Did the authors consider investigating their impacts?

Third, the novel thoracotomy approach was initiated in 2016, whereas the study was conducted between 2010 and 2018. Overall surgical outcomes of the recent era (after 2016) might be better compared with the prior era (before 2016). It might be recommended to compare clinical outcomes before and after 2016 to minimize such a bias.

Supplementary

The article’s supplementary files as

jtd-12-07-3911-coif.pdf (77.6KB, pdf)
DOI: 10.21037/jtd-20-1984

Acknowledgments

Funding: None.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Provenance and Peer Review: This article was a free submission to the editorial office, Journal of Thoracic Disease. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1984). The author has no conflicts of interest to declare.

References

  • 1.Carmona A, Hoang Minh T, Perrier S, et al. Minimally invasive surgery for left ventricular assist device implantation is safe and associated with a decreased risk of right ventricular failure. J Thorac Dis 2020;12:1496-506. 10.21037/jtd.2020.02.32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pasrija C, Sawan MA, Sorensen E, et al. Less invasive left ventricular assist device implantation may reduce right ventricular failure. Interact Cardiovasc Thorac Surg 2019;29:592-8. 10.1093/icvts/ivz143 [DOI] [PubMed] [Google Scholar]
  • 3.Imamura T, Kinugawa K, Kato N, et al. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 2014;78:625-33. 10.1253/circj.CJ-13-1201 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

The article’s supplementary files as

jtd-12-07-3911-coif.pdf (77.6KB, pdf)
DOI: 10.21037/jtd-20-1984

Articles from Journal of Thoracic Disease are provided here courtesy of AME Publications

RESOURCES